The Coviplasm trial begins today. It aims to test the effectiveness of transfusion of plasma from people healed to treat the disease. Professor Karine Lacombe, Head of Infectiology Service at Saint-Antoine Hospital in Paris, is responsible for coordinating it. It explains what it is, and why "passive immunity transfer" may offer hope in the treatment of covid-19 in the short term.

Ask all your questions on the #RadioOuverte social networks or by phone at 3921 (€ 0.50 / min. Donated to the Institut Pasteur). And find the answers to your questions in the podcast "My question Coronavirus".

Here are the instructions for listening to all the podcasts of Europe 1